Clinical Trial Update: Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial [Phase 2]

View source ↗

Summary

Phase 2 trial update for ivermectin in COVID-19 patients completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Drugs mentioned

• IVERMECTIN (Ivermectin)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Covid-19, Coronavirus Infection | Phase 2 | Status: COMPLETED | Results posted: 2020-12-17